Category: Design and innovation

On entrepreneurship and seizing opportunities to make healthcare safer

By Ana Luisa Neves, co-founder of momoby, GP and IGHI Research Fellow. 

At momoby, we believe every woman should have access to prenatal care, regardless of where she lives. To tackle this challenge, we’re developing a low cost, pocket-sized device that tests for diseases that could harm pregnancy, using a single drop of blood.

Celebrating our women at IGHI

It’s Women at Imperial Week, an opportunity for us to celebrate some of the fantastic females who help keep our Institute brimming with brilliance.

To mark the occasion, in honour of International Women’s Day, we spoke with a handful of women from across IGHI’s Centres to learn more about what they do, what makes them tick, and the females who inspire them the most.

Launching the NHS Digital Academy

By Rachel Dunscombe, CEO, NHS Digital Academy

Standing in the Royal Society on the 16th of April waiting for the participants to arrive was both surreal and exciting. Surreal because of the rapid journey our wonderful team had taken to make the programme happen – this had become a reality so quickly. Exciting because I couldn’t wait to get started – this programme is important for the system and for me something I am hugely committed to.

The Digital Academy operational team, of which I am a part, are all keen to ensure that this programme is as grounded in digital leaders’ practice as much as possible rather than being too high end academic.

Advancing patient outcomes through technological innovation – from science fiction to science fact

By IGHI guest blogger, Chris Bird, PG student from the MSC in Health Policy at the Centre for Health Policy and Project Manager in the System Engagement Programme at the National Institute for Health and Care Excellence (NICE)

At a recent conference I was lucky to listen to a guest lecture by Dr Kevin Fong. Kevin has a long standing interest in human space exploration and space medicine and has worked with NASA’s Human Adaptation and Countermeasures Office at the Johnson Space Centre in Houston. He’s travelled the world to meet medical innovators and has produced interesting documentaries for television showing the extreme scenarios in which healthcare and technology can be applied to further human survival.

Tackling Stroke with University Innovation

By guest blogger and Imperial alumnus Margaux Lesaffre

Stroke is the silent killer; there are no clear symptoms until people realise they can’t talk, move or even swallow. Annually, over 5 million deaths worldwide are caused by strokes, ranking this disease in the first ten leading cause of deaths.  In developed countries, the incidence of stroke is dropping, but the outcome is still severe with some stroke victims left permanently disabled.

So what’s the way forward?

University researchers have developed remarkable innovations that could deliver significantly more reliable diagnostics and treatment. This blog looks at different ways university research can tackle this insidious disease.

Innovations in biotechnology

By Student Challenges Competition runner up Nicolas Kylilis

Nicolas won the £2,500 prize money last year for his inventive idea for a new platform technology called DaPHNI for developing point-of-care medical diagnostic devices. The DaPHNI platform has the potential to have a large, multifaceted positive impact on global health both in developed countries, at healthcare centres, or as home diagnostic kits, as well as in developing countries.

The problem

In the past few decades, innovations in biotechnology have brought to the market small portable and affordable medical diagnostic devices that people can use to monitor their health, the so-called biosensors. Some examples of biosensor devices such as the pregnancy test strip and the blood glucose meter are widely known and used by the public.

Next Generation: Global Health Innovators

John Chetwood, winner of  the 2012 IGHI Student Challenges Competition tells us how he has put the £2000 prize money to good use.

Detecting a Silent Cancer

With the hepatologists at Imperial College London, I had been in rural Thailand investigating urinary biomarkers of ‘cholangiocarcinoma’ or simply put, cancer of the bile ducts. Though cholangiocarcinoma is thankfully rare in developed countries, it is showing worrying increases in incidence, and has shown little improvement in survival over the last 15 years.  There is still little hope of cure unless detected early and nearly everyone who develops this cancer will die from it.